Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

ClinicalTrials.gov ID: NCT00056576

Public ClinicalTrials.gov record NCT00056576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multicenter, Parallel Group Study to Establish Dose-Response, Safety, and Efficacy of Zonegran (Zonisamide) as Monotherapy in Patients With Newly Diagnosed Epilepsy

Study identification

NCT ID
NCT00056576
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
165 participants

Conditions and interventions

Interventions

  • Zonisamide Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Sep 30, 2004
Completion
Sep 30, 2004
Last update posted
Jul 17, 2011

2002 – 2004

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
UAB Epilepsy Center Birmingham Alabama 35294
North Alabama Neuroscience Huntsville Alabama 35801
Neurology Clinic, P.C. Northport Alabama 35476
Northridge Neurological Center Northridge California 91325
Coordinated Clinical Research San Diego California 92037
Neurology Associates Maitland Florida 32751
Bay Neurological Institute Panama City Florida 32405
Suncoast Neuroscience Associates, Inc. St. Petersburg Florida 33701
AMO Corporation Tallahassee Florida 32308
Florida Epilepsy & Seizure Disorder Center, PA Tampa Florida 33613
Neurology & Headache Specialist of Atlanta, LLC Decatur Georgia 30033
Southern Illinois University School of Medicine Dept. of Neurology Springfield Illinois 62707
Louisville Neuroscience Research Center Louisville Kentucky 40205
St. Agnes Health Care, Inc. Baltimore Maryland 21229
The Comprehensive Epilepsy Care Center Chesterfield Missouri 63017
Upstate Clinical Research Center Albany New York 12205
Dent Neurological Institute Orchard Park New York 14127
Epilepsy Institute of North Carolina Winston-Salem North Carolina 27103
River Hills Health Care Cincinnati Ohio 45219
Westmoreland Neurology Associates, Inc. Greensburg Pennsylvania 15601
CNS Research, INC East Providence Rhode Island 02914
Neurology Clinic of San Antonio San Antonio Texas 78229
Blue Ridge Research Center Roanoke Virginia 24014
Neurology & Neurosurgery Associates of Tacoma, Inc. P.S. Tacoma Washington 98405
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00056576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00056576 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →